Transaction DateRecipientSharesTypePriceValue
19th January 2021Scott D. Grimes400Open or private sale$115.05$46,020.00
19th January 2021Scott D. Grimes500Open or private sale$114.14$57,070.00
19th January 2021Scott D. Grimes200Open or private sale$118.07$23,614.00
19th January 2021Scott D. Grimes400Open or private sale$116.34$46,536.00
19th January 2021Scott D. Grimes500Open or private sale$112.68$56,340.00
14th January 2021Viii Lp Canaan7,468Open or private sale$5.45$40,696.12
13th January 2021Viii Lp Canaan10,000Open or private sale$5.58$55,798.00
12th January 2021Viii Lp Canaan10,000Open or private sale$5.68$56,822.00
7th January 2021Kirk Somers722Exercise of derivative$30.44$21,977.68
7th January 2021Kirk Somers983Open or private sale$135.08$132,783.64
Cardlytics
Cardlytics logo

Based on disclosure changes, sentiment, insider trading and news impact we give a rating of 6/10.


Cardlytics, Inc. engages in the development of marketing solutions through its purchase intelligence platform. It operates through the Cardlytics Direct and Other Platform Solutions segments. The company was founded on June 26, 2008 and is headquartered in Atlanta, GA.


Ticker: CDLX
Sector: Communication Services
Industry: Internet Content & Information
SEC Central Index Key (CIK): 1666071
Employees: 402
Exchange: NASDAQ
Auditor Opinion:

Disclosure Language changes
Red Flags
Fundamentals
Cash at Carrying Value: $98 M (0%)
Assets, Current: $146 M (-25%)
Property, Plant and Equipment, Net: $13 M (0%)
Other Assets, Noncurrent: $2 M (0%)
Assets: $183 M (-18%)
Long-term Debt, Current Maturities: $24 Th (0%)
Accounts Payable, Current: $1 M (-4%)
Accrued Liabilities, Current: $3 M (-45%)
Liabilities, Current: $42 M (-45%)
Long-term Debt, Excluding Current Maturities: $0 (-100%)
Liabilities: $53 M (-35%)
Common Stock, Value, Issued: $8 Th (0%)
Common Stock, Shares, Issued: $26 M (14%)
Additional Paid in Capital, Common Stock: $500 M (3%)
Retained Earnings (Accumulated Deficit): $372 M (9%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $3 M (106%)
Stockholders' Equity (Parent): $130 M (0%)
Liabilities and Equity: $183 M (-18%)
Revenue: $28 M (-61%)
Research and Development: $4 M (0%)
Sales and Marketing: $10 M (0%)
General and Administrative Expenses: $12 M (0%)
Restructuring Charges: $400 Th (-55%)
Operating Income/Loss: $20 M (-37%)
Other Income, net: $20 Th (0%)